ALLONK Trademark

Trademark Overview


On Thursday, March 4, 2021, a trademark application was filed for ALLONK with the United States Patent and Trademark Office. The USPTO has given the ALLONK trademark a serial number of 90559007. The federal status of this trademark filing is REGISTERED as of Tuesday, May 16, 2023. This trademark is owned by Artiva Biotherapeutics, Inc.. The ALLONK trademark is filed in the Pharmaceutical Products category with the following description:

Cells for medical or clinical use; Pharmaceutical preparations for the prevention of cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of breast cancer; Pharmaceutical preparations for the treatment of lymphoma; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the prevention and treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer; Therapeutic pharmaceutical for the treatment of breast cancer; Therapeutic pharmaceutical for the treatment of lymphoma; Therapeutic pharmaceutical for the treatment of tumors; Tumor suppressing agents; Anti-cancer preparations; Biological preparations for the treatment of cancer; Biological preparations for the treatment of breast cancer; Biological preparations for the treatment of lymphoma; Biological preparations for the treatment of tumors; Livin...
allonk

General Information


Serial Number90559007
Word MarkALLONK
Filing DateThursday, March 4, 2021
Status700 - REGISTERED
Status DateTuesday, May 16, 2023
Registration Number7056075
Registration DateTuesday, May 16, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 24, 2022

Trademark Statements


Name/Portrait Description and/or Consent StatementThe name(s), portrait(s), and/or signature(s) shown in the mark does not identify a particular living individual.
Goods and ServicesCells for medical or clinical use; Pharmaceutical preparations for the prevention of cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of breast cancer; Pharmaceutical preparations for the treatment of lymphoma; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the prevention and treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer; Therapeutic pharmaceutical for the treatment of breast cancer; Therapeutic pharmaceutical for the treatment of lymphoma; Therapeutic pharmaceutical for the treatment of tumors; Tumor suppressing agents; Anti-cancer preparations; Biological preparations for the treatment of cancer; Biological preparations for the treatment of breast cancer; Biological preparations for the treatment of lymphoma; Biological preparations for the treatment of tumors; Living cells for medical use; Pharmaceutical products for the treatment of cancer
Translation of Words in MarkThe English translation of "ALLO" in the mark is "OTHER"; The wording "NK" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 4, 2021
Primary Code005
First Use Anywhere DateThursday, April 8, 2021
First Use In Commerce DateWednesday, February 8, 2023

Trademark Owner History


Party NameArtiva Biotherapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92121

Party NameArtiva Biotherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92121

Party NameArtiva Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Tuesday, May 16, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 16, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, April 12, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 11, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, March 22, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, March 17, 2023USE AMENDMENT FILED
Wednesday, March 22, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 17, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, March 17, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 17, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 6, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, November 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, October 2, 2022EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, June 23, 2022EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, May 24, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 24, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 4, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 19, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, April 2, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 1, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 1, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 1, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 31, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 31, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 4, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 4, 2021NON-FINAL ACTION E-MAILED
Monday, October 4, 2021NON-FINAL ACTION WRITTEN
Monday, October 4, 2021REMOVED FROM TEAS PLUS
Monday, September 27, 2021ASSIGNED TO EXAMINER
Friday, June 4, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 8, 2021NEW APPLICATION ENTERED